Trials / Conditions / Advanced Intrahepatic Cholangiocarcinoma

Advanced Intrahepatic Cholangiocarcinoma

9 registered clinical trials studyying Advanced Intrahepatic Cholangiocarcinoma — 6 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Iparomlimab and Tuvonralimab Combined With GC in Advanced ICC NCT07152769	Fudan University	Phase 2
Not Yet Recruiting	Cryoablation Combined With SHR-1701 Plus Famitinib in Patients With Advanced Intrahepatic Cholangiocarcinoma. NCT07147088	Fudan University	Phase 2
Recruiting	HYPERION CCA: a Phase 2 Trial of Systemic Therapy With or Without Liver-directed Radiation Therapy for Patient NCT06858735	M.D. Anderson Cancer Center	Phase 2
Recruiting	Personalized Tumor Neoantigen mRNA Therapy for Advanced Intrahepatic Cholangiocarcinoma NCT06956716	Zhejiang University	Phase 1 / Phase 2
Active Not Recruiting	Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A Co NCT05564403	National Cancer Institute (NCI)	Phase 2
Unknown	Cryoablation Combined With Sintilimab Plus Lenvatinib in 1L Treatment of Advanced ICC (CASTLE-ICC-Chemo-free) NCT05835245	Fudan University	Phase 2
Recruiting	Clinical Study of VG161 in Advanced Intrahepatic Cholangiocarcinoma NCT06746480	CNBG-Virogin Biotech (Shanghai) Ltd.	Phase 2
Recruiting	HMPL-453 Tartrate in Advanced Intrahepatic Cholangiocarcinoma NCT04353375	Hutchmed	Phase 2 / Phase 3
Unknown	Calcitriol in Advanced Intrahepatic Cholangiocarcinoma NCT01039181	National Science and Technology Development Agency, Thailand	Phase 2